LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.1
92.25 27.76 4931 6873 0.7174 0.9182
MN20160318_Q01
D10
MCF 10A-H2B-mCherry Dasatinib
0.1
92.25 27.76 32 6873 0.0047 0.0180
MN20160318_Q01
M06
MCF 10A-H2B-mCherry Dasatinib
0.1
92.25 27.76 3540 6873 0.5150 0.8399
MN20160318_Q01
M06
MCF 10A-H2B-mCherry Dasatinib
0.1
93.96 27.76 911 6849 0.1330 0.5516
MN20160318_Q01
D10
MCF 10A-H2B-mCherry Dasatinib
0.1
93.96 27.76 4960 6849 0.7242 0.9204
MN20160318_Q01
D10
MCF 10A-H2B-mCherry Dasatinib
0.1
93.96 27.76 25 6849 0.0037 -0.0131
MN20160318_Q01
M06
MCF 10A-H2B-mCherry Dasatinib
0.1
93.96 27.76 3116 6849 0.4550 0.8113
MN20160318_Q01
M06
MCF 10A-H2B-mCherry Dasatinib
0.1
95.66 27.76 718 6712 0.1070 0.5081
MN20160318_Q01
D10
MCF 10A-H2B-mCherry Dasatinib
0.1
95.66 27.76 5043 6712 0.7513 0.9291
MN20160318_Q01
D10
MCF 10A-H2B-mCherry Dasatinib
0.1
95.66 27.76 24 6712 0.0036 -0.0182
MN20160318_Q01
M06
MCF 10A-H2B-mCherry Dasatinib
0.1
95.66 27.76 2216 6712 0.3301 0.7388
MN20160318_Q01
M06
MCF 10A-H2B-mCherry Dasatinib
0.17783
1.95 27.76 6 225 0.0267 -0.3979
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
1.95 27.76 386 225 1.7145 1.3909
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
1.95 27.76 1 225 0.0044 -0.6673
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
1.95 27.76 404 225 1.7944 1.4273
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
3.66 27.76 9 283 0.0317 -0.2852
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
3.66 27.76 562 283 1.9794 1.4515
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
3.66 27.76 1 283 0.0035 -0.6287
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
3.66 27.76 587 283 2.0674 1.4835
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
5.36 27.76 9 320 0.0281 -0.2733
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
5.36 27.76 655 320 2.0446 1.4494
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
5.36 27.76 1 320 0.0031 -0.6101
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
5.36 27.76 665 320 2.0758 1.4599
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
7.06 27.76 6 360 0.0167 -0.3392
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
7.06 27.76 725 360 2.0139 1.4170
MN20160318_Q01
E22